172 related articles for article (PubMed ID: 26928381)
21. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
Ranganathan S; Webber S; Ahuja S; Jaffe R
Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
[TBL] [Abstract][Full Text] [Related]
22. Post-transplantation lymphoproliferative disease in pediatric liver recipients in Taiwan.
Hsu CT; Chang MH; Ho MC; Chang HH; Lu MY; Jou ST; Ni YH; Chen HL; Hsu HY; Wu JF
J Formos Med Assoc; 2019 Nov; 118(11):1537-1545. PubMed ID: 30630698
[TBL] [Abstract][Full Text] [Related]
23. Lymphopenia at diagnosis predicts survival of patients with immunodeficiency-associated lymphoproliferative disorders.
Watanabe M; Kanda J; Hishizawa M; Nishikori M; Kondo T; Yamashita K; Takaori-Kondo A
Ann Hematol; 2020 Jul; 99(7):1565-1573. PubMed ID: 32436013
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
[TBL] [Abstract][Full Text] [Related]
25. Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients.
Trusson R; Serre JE; Szwarc I; Brunot V; Garrigue V; Delmas S; Kanouni T; Cartron G; Mourad G
Transplant Proc; 2016; 48(6):1927-33. PubMed ID: 27569924
[TBL] [Abstract][Full Text] [Related]
26. A retrospective analysis of post-transplant lymphoproliferative disorder following liver transplantation.
Fararjeh FA; Mahmood S; Tachtatzis P; Yallop D; Devereux S; Patten P; Agrawal K; Suddle A; O'Grady J; Heaton N; Marcus R; Kassam S
Eur J Haematol; 2018 Jan; 100(1):98-103. PubMed ID: 29094407
[TBL] [Abstract][Full Text] [Related]
27. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
28. Posttransplant lymphoproliferative disease: treatment and outcome in renal transplant recipients.
Soler MJ; Puig JM; Mir M; Parrilla J; Pedro C; Salar A; Serrano S; Lloveras J
Transplant Proc; 2003 Aug; 35(5):1709-13. PubMed ID: 12962767
[TBL] [Abstract][Full Text] [Related]
29. Characteristics, risks, and outcomes of post-transplant lymphoproliferative disease >3 years after pediatric heart transplant: A multicenter analysis.
West SC; Friedland-Little JM; Schowengerdt KO; Naftel DC; Pruitt Freeze E; Smith KS; Urschel S; Michaels MG; Kirklin JK; Feingold B
Clin Transplant; 2019 May; 33(5):e13521. PubMed ID: 30861200
[TBL] [Abstract][Full Text] [Related]
30. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
[TBL] [Abstract][Full Text] [Related]
31. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience.
Trofe J; Buell JF; Beebe TM; Hanaway MJ; First MR; Alloway RR; Gross TG; Succop P; Woodle ES
Am J Transplant; 2005 Apr; 5(4 Pt 1):775-80. PubMed ID: 15760401
[TBL] [Abstract][Full Text] [Related]
32. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
[TBL] [Abstract][Full Text] [Related]
33. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
34. Racial and Ethnic Disparities in the Pediatric Hodgkin Lymphoma Population.
Grubb WR; Neboori HJ; Diaz AD; Li H; Kwon D; Panoff J
Pediatr Blood Cancer; 2016 Mar; 63(3):428-35. PubMed ID: 26524117
[TBL] [Abstract][Full Text] [Related]
35. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
[TBL] [Abstract][Full Text] [Related]
36. Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.
Hori YS; Nagakita K; Ebisudani Y; Aoi M; Fukuhara T; Shinno Y
World Neurosurg; 2018 Jun; 114():230-234. PubMed ID: 29609086
[TBL] [Abstract][Full Text] [Related]
37. CD30 expression and survival in posttransplant lymphoproliferative disorders.
Kinch A; Amini RM; Hollander P; Molin D; Sundström C; Enblad G
Acta Oncol; 2020 Jun; 59(6):673-680. PubMed ID: 32102582
[No Abstract] [Full Text] [Related]
38. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569
[TBL] [Abstract][Full Text] [Related]
39. Post-transplant lymphoproliferative disease in liver transplant recipients.
Rubio-Manzanares Dorado M; Álamo Martínez JM; Bernal Bellido C; Marín Gómez LM; Suárez Artacho G; Cepeda Franco C; Wang J; Gómez Bravo MÁ; Padillo FJ
Rev Esp Enferm Dig; 2017 Jun; 109(6):406-413. PubMed ID: 28508661
[TBL] [Abstract][Full Text] [Related]
40. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
Aull MJ; Buell JF; Trofe J; First MR; Alloway RR; Hanaway MJ; Wagoner L; Gross TG; Beebe T; Woodle ES
Transplantation; 2004 Dec; 78(11):1676-82. PubMed ID: 15591959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
